Cargando…
Phenotypic factors associated with amisulpride‐induced weight gain in first‐episode psychosis patients (from the OPTiMiSE cohort)
OBJECTIVE: Antipsychotic‐induced weight gain (AiWG) is a debilitating adverse effect of most antipsychotics. First‐episode psychosis patients are particularly vulnerable to the detrimental consequences of AiWG. Amisulpride has good efficacy and tolerability. We here aimed to identify the phenotypic...
Autores principales: | Pandit, R., Cianci, D., ter Hark, S. E., Winter‐van Rossum, I., Ebdrup, B. H., Broberg, B. V., Garcia‐Portilla, M. P., Bobes, J., Vinkers, C. H., Kahn, R. S., Guloksuz, S., Huitema, A. D. R., Luykx, J. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771865/ https://www.ncbi.nlm.nih.gov/pubmed/31323113 http://dx.doi.org/10.1111/acps.13074 |
Ejemplares similares
-
A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort)
por: ter Hark, Sophie E, et al.
Publicado: (2020) -
Searching for bridges between psychopathology and real-world functioning in first-episode psychosis: a network analysis from the OPTiMiSE trial
por: Dal Santo, F., et al.
Publicado: (2023) -
Searching for bridges between psychopathology and real-world functioning in first-episode psychosis: A network analysis from the OPTiMiSE trial
por: Dal Santo, Francesco, et al.
Publicado: (2022) -
Negative symptoms in First-Episode Schizophrenia related to morphometric alterations in orbitofrontal and superior temporal cortex: the OPTiMiSE study
por: Demjaha, Arsime, et al.
Publicado: (2023) -
Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study
por: Martinuzzi, Emanuela, et al.
Publicado: (2019)